Fig. 4

Expressions of ZNF436 in different sub-types of neuroblastoma. (a) Box plots showed the relative ZNF436 expression levels in neuroblastoma patients with or without MYCN amplification in E-MTAB-1781, GSE13136, GSE73517, TARGET, GSE16476, GSE62564 and GSE85047 datasets. P values were performed using Student’s t test. (b) The relative ZNF436 expression levels in neuroblastoma patients with age of diagnosis ≥ 18month or < 18months in E-MTAB-1781, GSE13136, GSE73517, TARGET, GSE16476, GSE62564 and GSE85047 datasets. (c) The relative ZNF436 expression levels in neuroblastoma patients with different tumor stages in E-MTAB-1781, GSE73517, GSE16476, GSE62564 and GSE85047 datasets